University of California San Francisco
Give to UCSFA new UCSF study reports for the first time that significant hearing issues often occur among adult survivors of the most common forms of cancer.
The latest advances in cancer care and research will be showcased at the annual American Society of Clinical Oncology (ASCO) Annual Meeting, the world’s largest clinical cancer meeting.
Eric J. Small, MD, was announced as one of the winners of the 10th annual Giants of Cancer Care® awards. Small is being recognized for his achievements in the clinical practice and research of genitourinary cancers.
Leading UCSF cancer researchers will present at this year’s annual meeting of the American Association for Cancer Research conference, held April 8-13, 2022, in New Orleans, on topics such as updates on cancer’s environmental factors, targetable protein interactions, and effects on immune metabolism.
A new prostate cancer test developed by UCSF and UCLA detects cancer cells that have spread to lymph nodes both inside and outside the pelvis.
The imaging technique for prostate cancer locates cancer lesions in the pelvic area and other parts of the body to which the tumors have migrated.
None of the individual tumor genetic differences that were identified are likely to explain significant differences in health outcomes or to prevent Black Americans from benefiting from a new generation of precision prostate cancer therapies, researchers say, as long as the therapies are applied equitably.
Cancer specialists from UCSF will present new research findings at the annual scientific program of the American Society of Clinical Oncology, the world’s largest clinical cancer research meeting.
A future in which precision medicine benefits everyone is not guaranteed. For that to happen, UCSF experts argue, the health care industry must first tackle today’s health disparities, including differences in disease outcomes and access to care based on race, gender, and socioeconomic status.
The UCSF Benioff Initiative for Prostate Cancer Research, made possible by a $35 million gift from Marc and Lynne Benioff, will bring together scientists and physicians who seek to push the boundaries of prostate cancer research and devise new strategies to combat the disease.
Study, led by UCSF, raises intriguing questions about whether the biology of low-risk prostate cancer in black men is distinct from that of other ethnicities.